Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections

Thrombosis and Haemostasis

Volumn 95, Issue 2, 2006, Pages 282-287

  Asakura, Hidesaku ^a   Wada, Hideo ^b   Okamoto, Kohji ^c   Iba, Toshiaki ^d   Uchiyama, Toshimasa ^e   Eguchi, Yutaka ^f   Kawasugi, Kazuo ^g   Koga, Shin ^b   Mayumi, Toshihiko ^h   Koike, Kaoru ⁱ   Gando, Satoshi ^j  

^a KANAZAWA UNIVERSITY   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^e National Hospital Organization   (Japan)

^f SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

D dimer; DIC; Mortality; PPIC; TAT

Indexed keywords

D DIMER; HEPARIN; MOLECULAR MARKER; PLASMIN; PLASMIN INHIBITOR; PROTEINASE INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; EVALUATION; FEMALE; HEMOSTASIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; ANTIPLASMIN; ANTITHROMBIN III; BIOLOGICAL MARKERS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; INFECTION; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMIN; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33645539006     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-04-0286     Document Type: Article

References (21)

1. Kobayashi N, Maegawa T, Takada M, et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haemotol 1983; 49: 265-75.
2. Taylor Jr FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation -On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001; 86: 1327-30.
3. Wada H, Gabazza EC, Asakura H, et al. Comparison between diagnostic criteria for disseminated intravascular coagulation (DIC): The diagnostic criteria for overt-DIC of the International Society of Thrombosis and Haemostasis (ISTH) and those of the Japanese Ministry of Health and Welfare. Am J Hematol 2003; 74: 17-22.
4. Wada H, Wakita Y, Nakase T, Shimura M, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 74: 848-52.
5. Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 1993; 43: 190-4.
6. Wada H, Wakita Y, Nakase T et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 1996; 51: 255-60.
7. Gando S, Wada H, Asakura H et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 2005; 11: 71-6.
8. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human protein C for severe sepsis. N Engl J Med 2001; 8: 699-709.
9. Gando S, Kameue T, Nanzaki S, et al. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996; 75: 224-8.
10. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 74: 848-52.
11. Asakura H, Ontachi Y, Mizutani T, et al. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Eur J Haematol 2001; 67: 170-5.
12. Vincent JL, Moreno R, Takahara J. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-10.
13. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 1997; 2: 20-4.
14. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117-23.
15. Taylor FB Jr, Chang A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-34.
16. Asakura H, Suga Y, Aoshima K, et al. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats. Crit Care Med 2002; 30: 161-4.
17. Wada H, Mori Y, Sakakura M, et al. High plasma levels of fibrinogen are associated with poor outcome. Am J Hematol 2003; 72:1-7.
18. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-35.
19. Wada H, Sakuragawa N, Mori Y, et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 1999; 60: 273-8.
20. Dempfle CE, Wurst M, Smolinski M, et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 2004; 91: 812-8.
21. Pralong G, Calandra T, Glauser MP, et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989; 61: 459-62.